tirzepatide cardiovascular outcomes trial results july 2025 In the SUMMIT trial, researchers examined of treatment with in patients with heart failure with preserved ejection fraction and obesity. Full and Plain Language Summary: https://nej.md/4hRGaTY Medthreads TP-Active Subscription:3 months Consumer Option - MHBP

tirzepatide cardiovascular outcomes trial results july 2025 In the SUMMIT trial, researchers examined of treatment with in patients with heart failure with preserved ejection fraction and obesity. Full and Plain Language Summary: https://nej.md/4hRGaTY Medthreads TP-Active Subscription:3 months Consumer Option - MHBP

Consumer Option - MHBP Federal Health Plans

Regular monitoring also catches any rare thyroid-related side effects early, though tirzepatide itself does not trigger hypothyroidism or thyroid inflammation

TP-Active

Subscription:3 months

Medically supervised weight loss with GLP-1 options, personalized prescriptions, and expert 1:1 counseling